Ginkgo biloba in the treatment of autistic disorder
Phase 2
- Conditions
- Childhood autism.Childhood autism
- Registration Number
- IRCT201012031556N19
- Lead Sponsor
- Tehran University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 40
Inclusion Criteria
Inclusion Criteria: DSM IV clinical diagnosis of autism, children and adolescents between the ages of 3 and 12 years (inclusive),
Exclusion Criteria
Presence of any active medical problem, any diagnosis in Axis I and II except for mental retatdation, history of allergy to Ginkgo Biloba, receiving any psychotropic medications during past two weeks prior to the trial
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Severity of Autism. Timepoint: Baseline and weerks 2, 4, 6, 8, 10. Method of measurement: Aberrant Behavior Checklist-Community (ABC-C) Rating Scale.
- Secondary Outcome Measures
Name Time Method